Alnylam Pharmaceuticals Inc
ALNYHealthcare|Biotechnology|USA
$298.76
-14.03 (-4.49%)
Tangible Book
$8.06
Graham Number
$32.23
Ownership Breakdown
—
Institutional
—
Insider
—
Float
—
Shares Outstanding
Insider Trades (291)
| Insider | Position | Date | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| PYOTT DAVID E I | Director | 2026-06-01 | SELL | 3,830 | $299.18 | $1145.9K |
| McLaughlin Melissa | Chief Human Resources Officer | 2026-04-06 | SELL | 3,910 | $325.92 | $1274.3K |
| Garg Pushkal | EVP Chief R&D | 2026-03-05 | SELL | 4,713 | $323.53 | $1524.8K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-03-05 | SELL | 1,291 | $323.54 | $417.7K |
| Greenstreet Yvonne | CEO | 2026-03-04 | SELL | 2,933 | $323.08 | $947.6K |
| Poulton Jeffrey V. | EVP, CFO | 2026-03-04 | SELL | 2,468 | $323.08 | $797.4K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2026-03-04 | SELL | 2,309 | $323.08 | $746K |
| Garg Pushkal | EVP Chief R&D | 2026-03-03 | SELL | 3,492 | $323.63 | $1130.1K |
| Poulton Jeffrey V. | EVP, CFO | 2026-03-02 | SELL | 2,206 | $327.65 | $722.8K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2026-03-02 | SELL | 1,598 | $327.65 | $523.6K |
| Greenstreet Yvonne | CEO | 2026-03-02 | SELL | 6,799 | $327.65 | $2227.7K |
| Garg Pushkal | EVP Chief R&D | 2026-02-27 | SELL | 4,627 | $331.34 | $1533.1K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-02-17 | SELL | 4,000 | $321.24 | $1285K |
| Garg Pushkal | EVP Chief R&D | 2026-02-13 | SELL | 2,242 | $310.08 | $695.2K |
| Greenstreet Yvonne | CEO | 2026-02-13 | SELL | 6,958 | $310.08 | $2157.5K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2026-02-13 | SELL | 1,959 | $310.08 | $607.4K |
| Poulton Jeffrey V. | EVP, CFO | 2026-02-13 | SELL | 2,242 | $310.08 | $695.2K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2026-01-13 | SELL | 3,800 | $367.37 | $1396K |
| Garg Pushkal | EVP Chief R&D | 2026-01-12 | SELL | 1,510 | $362.87 | $547.9K |
| Greenstreet Yvonne | CEO | 2026-01-12 | SELL | 9,577 | $362.86 | $3475.1K |
| Poulton Jeffrey V. | EVP, CFO | 2026-01-12 | SELL | 2,780 | $362.87 | $1008.8K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2026-01-12 | SELL | 1,510 | $362.87 | $547.9K |
| Greenstreet Yvonne | CEO | 2025-11-13 | SELL | 25,650 | $452.75 | $11613K |
| Garg Pushkal | EVP Chief R&D | 2025-10-03 | SELL | 5,959 | $451.76 | $2692K |
| Poulton Jeffrey V. | EVP, CFO | 2025-10-02 | SELL | 3,821 | $452.05 | $1727.3K |
| Greenstreet Yvonne | CEO | 2025-10-02 | SELL | 8,924 | $452.05 | $4034.1K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-10-02 | SELL | 1,405 | $452.05 | $635.1K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-10-02 | SELL | 2,441 | $452.05 | $1103.5K |
| Reitan Colleen F | Director | 2025-09-09 | SELL | 18,000 | $467.6 | $8416.8K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-08-29 | SELL | 3,474 | $448.37 | $1557.6K |
| Garg Pushkal | EVP Chief R&D | 2025-08-19 | SELL | 2,851 | $455.89 | $1299.7K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-08-18 | SELL | 1,396 | $453.27 | $632.8K |
| Poulton Jeffrey V. | EVP, CFO | 2025-08-18 | SELL | 2,274 | $453.27 | $1030.7K |
| Greenstreet Yvonne | CEO | 2025-08-18 | SELL | 6,979 | $453.27 | $3163.4K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-08-18 | SELL | 1,396 | $453.27 | $632.8K |
| BONNEY MICHAEL W | Director | 2025-08-18 | SELL | 11,250 | $450 | $5062.5K |
| Ausiello Dennis A | Director | 2025-08-14 | SELL | 31,448 | $436.58 | $13729.6K |
| Greenstreet Yvonne | CEO | 2025-06-02 | SELL | 50,937 | $305 | $15535.8K |
| BONNEY MICHAEL W | Director | 2025-05-15 | SELL | 11,250 | $277.71 | $3124.2K |
| Reitan Colleen F | Director | 2025-04-16 | SELL | 36 | $232.86 | $8.4K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-03-24 | SELL | 9,766 | $293.36 | $2865K |
| PYOTT DAVID E I | Director | 2025-03-24 | SELL | 7,440 | $299 | $2224.6K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-03-04 | SELL | 2,755 | $242.94 | $669.3K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-03-04 | SELL | 2,557 | $242.92 | $621.1K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-03-03 | SELL | 471 | $243.78 | $114.8K |
| Poulton Jeffrey V. | EVP, CFO | 2025-03-03 | SELL | 1,264 | $243.78 | $308.1K |
| Greenstreet Yvonne | CEO | 2025-03-03 | SELL | 3,877 | $243.79 | $945.2K |
| Greenstreet Yvonne | CEO | 2025-02-28 | SELL | 2,900 | $241.69 | $700.9K |
| Poulton Jeffrey V. | EVP, CFO | 2025-02-28 | SELL | 796 | $241.7 | $192.4K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2025-02-28 | SELL | 513 | $241.68 | $124K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-28 | SELL | 935 | $241.69 | $226K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-28 | SELL | 496 | $241.69 | $119.9K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2025-02-18 | SELL | 2,103 | $252.71 | $531.4K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-02-18 | SELL | 3,109 | $253.43 | $787.9K |
| Greenstreet Yvonne | CEO | 2025-02-14 | SELL | 1,213 | $255.17 | $309.5K |
| Poulton Jeffrey V. | EVP, CFO | 2025-02-14 | SELL | 967 | $255.17 | $246.7K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2025-01-27 | SELL | 52,592 | $285 | $14988.7K |
| SHARP PHILLIP A | Director | 2025-01-23 | SELL | 11,250 | $275 | $3093.8K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-12-12 | SELL | 1,752 | $251 | $439.8K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-11-27 | SELL | 3,000 | $251.65 | $755K |
| Greenstreet Yvonne | CEO | 2024-11-26 | SELL | 5,219 | $250.98 | $1309.9K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-11-26 | SELL | 1,682 | $250.98 | $422.1K |
| Poulton Jeffrey V. | EVP, CFO | 2024-11-26 | SELL | 1,682 | $250.98 | $422.1K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2024-11-26 | SELL | 1,469 | $250.98 | $368.7K |
| Reitan Colleen F | Director | 2024-10-17 | BUY | 36 | $287.85 | $10.4K |
| Greenstreet Yvonne | CEO | 2024-08-20 | SELL | 15,000 | $280 | $4200K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-08-12 | SELL | 22,025 | $270.99 | $5968.6K |
| Ausiello Dennis A | Director | 2024-08-06 | SELL | 20,250 | $262 | $5305.5K |
| Greenstreet Yvonne | CEO | 2024-08-01 | SELL | 15,148 | $270 | $4090K |
| Greenstreet Yvonne | CEO | 2024-07-11 | SELL | 7,093 | $261 | $1851.3K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-06-25 | SELL | 2,103 | $230.99 | $485.8K |
| Greenstreet Yvonne | CEO | 2024-06-25 | SELL | 8,301 | $230.99 | $1917.4K |
| Poulton Jeffrey V. | EVP, CFO | 2024-06-25 | SELL | 1,605 | $231 | $370.8K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2024-06-25 | SELL | 1,605 | $231 | $370.8K |
| Fitzgerald Kevin Joseph | CSO & EVP, Head of Research | 2024-06-25 | SELL | 1,198 | $230.99 | $276.7K |
| SCHULMAN AMY W | Director | 2024-06-25 | SELL | 8,500 | $240 | $2040K |
| PYOTT DAVID E I | Director | 2024-06-24 | SELL | 32,450 | $220.69 | $7161.4K |
| SCHULMAN AMY W | Director | 2024-05-29 | SELL | 21,700 | $148.6 | $3224.6K |
| SHARP PHILLIP A | Director | 2024-02-29 | SELL | 30,000 | $151.34 | $4540.2K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2024-02-28 | SELL | 501 | $155.3 | $77.8K |
| Poulton Jeffrey V. | EVP, CFO | 2024-02-28 | SELL | 574 | $155.3 | $89.1K |
| Greenstreet Yvonne | CEO | 2024-02-28 | SELL | 2,932 | $155.31 | $455.4K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2024-02-28 | SELL | 574 | $155.3 | $89.1K |
| Franchini Indrani Lall | EVP, CLO & Secretary | 2024-02-28 | SELL | 329 | $155.3 | $51.1K |
| Franchini Indrani Lall | EVP, CLO & Secretary | 2024-02-02 | SELL | 1,591 | $170.99 | $272K |
| BONNEY MICHAEL W | Director | 2023-12-27 | SELL | 30,000 | $195 | $5850K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-08-07 | SELL | 7,627 | $184.78 | $1409.3K |
| Poulton Jeffrey V. | EVP, CFO | 2023-08-04 | SELL | 3,460 | $185.85 | $643K |
| Greenstreet Yvonne | CEO | 2023-08-04 | SELL | 4,057 | $185.85 | $754K |
| Vaishnaw Akshay | President | 2023-08-04 | SELL | 4,057 | $185.85 | $754K |
| BONNEY MICHAEL W | Director | 2023-08-03 | SELL | 6,448 | $185.38 | $1195.3K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-04-28 | SELL | 4,294 | $197.12 | $846.4K |
| Greenstreet Yvonne | CEO | 2023-04-27 | SELL | 7,615 | $194.59 | $1481.8K |
| Poulton Jeffrey V. | EVP, CFO | 2023-04-27 | SELL | 977 | $194.59 | $190.1K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2023-04-27 | SELL | 1,476 | $194.59 | $287.2K |
| Vaishnaw Akshay | President | 2023-04-27 | SELL | 2,392 | $194.59 | $465.5K |
| Franchini Indrani Lall | EVP, CLO & Secretary | 2023-04-06 | SELL | 3,500 | $210 | $735K |
| Garg Pushkal | CMO & EVP Dev & Med Affairs | 2023-03-03 | SELL | 18,072 | $200 | $3614.4K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2023-02-03 | SELL | 5,025 | $230.19 | $1156.7K |
| Franchini Indrani Lall | EVP, CLO & Secretary | 2023-02-02 | SELL | 1,675 | $226.01 | $378.6K |
| Ausiello Dennis A | Director | 2022-11-21 | SELL | 22,500 | $220 | $4950K |
| SHARP PHILLIP A | Director | 2022-08-15 | SELL | 33,670 | $230.49 | $7760.6K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2022-08-05 | SELL | 3,595 | $214.18 | $770K |
| Tanguler Tolga | EVP, Chief Commercial Officer | 2022-07-05 | SELL | 1,754 | $150 | $263.1K |
| SHARP PHILLIP A | Director | 2022-02-09 | SELL | 30,000 | $150 | $4500K |
| Vaishnaw Akshay | President, R&D | 2021-12-23 | SELL | 2,879 | $190.93 | $549.7K |
| MARAGANORE JOHN | CEO | 2021-11-12 | SELL | 33,978 | $171.52 | $5827.9K |
| MARAGANORE JOHN | CEO | 2021-08-13 | SELL | 33,979 | $199.78 | $6788.3K |
| Vaishnaw Akshay | President, R&D | 2021-08-09 | SELL | 10,834 | $200 | $2166.8K |
| Greenstreet Yvonne | President & COO | 2021-08-06 | SELL | 53,064 | $199 | $10559.7K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2021-08-05 | SELL | 10,000 | $188.95 | $1889.5K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2021-07-12 | SELL | 6,812 | $178.96 | $1219.1K |
| Vaishnaw Akshay | President, R&D | 2021-06-18 | SELL | 14,708 | $175 | $2573.9K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2021-06-09 | SELL | 1,734 | $154 | $267K |
| Vaishnaw Akshay | President, R&D | 2021-04-21 | SELL | 6,438 | $137.36 | $884.3K |
| MARAGANORE JOHN | CEO | 2021-02-25 | SELL | 33,979 | $147.31 | $5005.4K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2021-01-13 | SELL | 9,027 | $169.9 | $1533.7K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2021-01-12 | SELL | 15,699 | $159.91 | $2510.4K |
| Greenstreet Yvonne | President & COO | 2021-01-12 | SELL | 3,125 | $161 | $503.1K |
| PAUL STEVEN M | Director | 2020-12-18 | SELL | 15,000 | $140 | $2100K |
| SHARP PHILLIP A | Director | 2020-11-25 | SELL | 30,000 | $124.89 | $3746.7K |
| MARAGANORE JOHN | CEO | 2020-11-19 | SELL | 34,765 | $124.23 | $4318.9K |
| Vaishnaw Akshay | President, R&D | 2020-09-29 | SELL | 971 | $140 | $135.9K |
| Greene Barry E | President | 2020-09-09 | SELL | 44,530 | $123.23 | $5487.4K |
| MARAGANORE JOHN | CEO | 2020-08-20 | SELL | 34,765 | $136.13 | $4732.6K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2020-07-13 | SELL | 47,250 | $160.67 | $7591.7K |
| Greenstreet Yvonne | COO | 2020-07-10 | SELL | 46,639 | $161 | $7508.9K |
| Greenstreet Yvonne | COO | 2020-07-09 | SELL | 11,236 | $161 | $1809K |
| Greene Barry E | President | 2020-07-07 | SELL | 22,265 | $159.99 | $3562.2K |
| Vaishnaw Akshay | President, R&D | 2020-06-22 | SELL | 970 | $151.07 | $146.5K |
| MARAGANORE JOHN | CEO | 2020-05-20 | SELL | 34,765 | $143.22 | $4979K |
| Greene Barry E | President | 2020-05-06 | SELL | 22,265 | $149.99 | $3339.5K |
| Greenstreet Yvonne | COO | 2020-05-06 | SELL | 57,811 | $148.65 | $8593.6K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2020-04-20 | SELL | 10,000 | $139 | $1390K |
| Vaishnaw Akshay | President, R&D | 2020-04-20 | SELL | 21,971 | $140 | $3075.9K |
| MARAGANORE JOHN | CEO | 2020-02-20 | SELL | 34,765 | $131.85 | $4583.8K |
| SHARP PHILLIP A | Director | 2020-02-12 | SELL | 30,000 | $130 | $3900K |
| PAUL STEVEN M | Director | 2020-02-10 | SELL | 30,000 | $130 | $3900K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2020-02-10 | SELL | 10,000 | $129 | $1290K |
| Greenstreet Yvonne | COO | 2020-02-10 | SELL | 16,142 | $127.64 | $2060.4K |
| Vaishnaw Akshay | President, R&D | 2020-02-07 | SELL | 23,708 | $125 | $2963.5K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2020-01-29 | SELL | 6,337 | $119 | $754.1K |
| KEATING LAURIE | EVP, Chief Legal Officer | 2020-01-27 | SELL | 41,037 | $117.7 | $4830.1K |
| Fanucci Marsha | Director | 2019-11-20 | SELL | 75,000 | $100 | $7500K |
| Greenstreet Yvonne | COO | 2019-11-20 | SELL | 8,404 | $105 | $882.4K |
| SHARP PHILLIP A | Director | 2019-11-18 | SELL | 15,000 | $91.71 | $1375.7K |
| Greene Barry E | President | 2019-10-22 | SELL | 58,913 | $89.99 | $5301.6K |
| MARAGANORE JOHN | CEO | 2019-10-14 | SELL | 49,456 | $79.45 | $3929.3K |
| MARAGANORE JOHN | CEO | 2019-05-15 | SELL | 49,457 | $70 | $3462K |
| SHARP PHILIP A | Director | 2019-04-15 | SELL | 15,000 | $88.23 | $1323.5K |
| Greenstreet Yvonne | EVP, COO | 2018-08-30 | SELL | 2,500 | $120 | $300K |
| MARAGANORE JOHN | CEO | 2018-07-25 | SELL | 50,000 | $105.39 | $5269.5K |
| KEATING LAURIE | SVP, GC & Secretary | 2018-06-20 | SELL | 1,563 | $105.04 | $164.2K |
| CLARKE JOHN K | Director | 2018-05-31 | SELL | 15,000 | $100.31 | $1504.7K |
| Greenstreet Yvonne | EVP, COO | 2018-03-26 | SELL | 7,221 | $136.54 | $986K |
| KEATING LAURIE | SVP, GC & Secretary | 2018-03-20 | SELL | 1,562 | $149.83 | $234K |
| Vaishnaw Akshay | President, R&D | 2018-03-14 | SELL | 88,554 | $143.1 | $12672.1K |
| Greene Barry E | President | 2018-03-14 | SELL | 38,460 | $143.1 | $5503.6K |
| KEATING LAURIE | SVP, GC & Secretary | 2018-03-13 | SELL | 20,000 | $145 | $2900K |
| Ausiello Dennis A | Director | 2018-03-13 | SELL | 17,117 | $150 | $2567.6K |
| SHARP PHILIP A | Director | 2018-03-13 | SELL | 15,000 | $149 | $2235K |
| SCHIMMEL PAUL | Director | 2018-03-13 | SELL | 27,823 | $150 | $4173.5K |
| SHARP PHILIP A | Director | 2018-03-09 | SELL | 15,000 | $129 | $1935K |
| Mason Michael | VP, Finance and Treasurer | 2018-01-04 | SELL | 36,745 | $131.59 | $4835.3K |
| KEATING LAURIE | SVP, GC and Secretary | 2017-12-01 | SELL | 30,000 | $135.89 | $4076.7K |
| MARAGANORE JOHN | CEO | 2017-11-22 | SELL | 73,415 | $130.9 | $9610K |
| MARAGANORE JOHN | CEO | 2017-11-15 | SELL | 74,000 | $126.86 | $9387.6K |
| Ausiello Dennis A | Director | 2017-11-02 | SELL | 20,000 | $130 | $2600K |
| Vaishnaw Akshay | EVP, R&D | 2017-10-30 | SELL | 33,666 | $121.46 | $4089.1K |
| Greene Barry E | President | 2017-10-02 | SELL | 85,316 | $125 | $10664.5K |
| Greene Barry E | President | 2017-09-20 | SELL | 76,815 | $100 | $7681.5K |
| Sanofi | 10% Owner | 2017-05-31 | BUY | 297,501 | $71.87 | $21381.4K |
| KEATING LAURIE | SVP, GC and Secretary | 2017-05-30 | BUY | 11,500 | $65.35 | $751.5K |
| Vaishnaw Akshay | EVP, R&D | 2017-05-23 | SELL | 11,000 | $75 | $825K |
| Mason Michael | VP, Finance and Treasurer | 2017-05-16 | SELL | 9,375 | $70 | $656.3K |
| Vaishnaw Akshay | SVP, R&D | 2017-05-15 | SELL | 43,750 | $65 | $2843.8K |
| SHARP PHILIP A | Director | 2017-02-01 | SELL | 25,000 | $39.8 | $995K |
| SHARP PHILIP A | Director | 2017-01-25 | SELL | 15,000 | $37.95 | $569.3K |
| SHARP PHILIP A | Director | 2017-01-18 | SELL | 15,000 | $37.83 | $567.5K |
| Greene Barry E | President | 2016-12-01 | SELL | 31,825 | $42.99 | $1368.2K |
| Vaishnaw Akshay | EVP, R&D, CMO | 2016-11-30 | SELL | 29,165 | $44.99 | $1312.1K |
| PYOTT DAVID E I | Director | 2016-10-13 | BUY | 27,900 | $37 | $1032.3K |
| MARAGANORE JOHN | CEO | 2016-07-20 | SELL | 30,151 | $64.69 | $1950.5K |
| MARAGANORE JOHN | CEO | 2016-04-20 | SELL | 30,151 | $67.46 | $2034K |
| BONNEY MICHAEL W | Director | 2016-03-09 | BUY | 2,000 | $58.36 | $116.7K |
| Gros David-Alexandre C | SVP, Chief Business Officer | 2016-02-22 | BUY | 1,000 | $62.75 | $62.8K |
| Sanofi | 10% Owner | 2016-02-01 | BUY | 205,030 | $69.75 | $14300.8K |
| MARAGANORE JOHN | CEO | 2016-01-20 | SELL | 30,152 | $71.78 | $2164.3K |
| SHARP PHILIP A | Director | 2015-12-04 | SELL | 30,000 | $109 | $3270K |
| MARAGANORE JOHN | CEO | 2015-12-02 | SELL | 58,689 | $104.87 | $6154.7K |
| MARAGANORE JOHN | CEO | 2015-11-20 | SELL | 58,690 | $102.88 | $6038K |
| STARR KEVIN P | Director | 2015-11-12 | SELL | 75,000 | $103.89 | $7791.8K |
| Vaishnaw Akshay | EVP, R&D, CMO | 2015-06-16 | SELL | 8,750 | $128.83 | $1127.3K |
| Mason Michael | VP, Finance and Treasurer | 2015-06-01 | SELL | 4,791 | $131.84 | $631.6K |
| Greene Barry E | President and COO | 2015-05-26 | SELL | 67,379 | $125 | $8422.4K |
| BONNEY MICHAEL W | Director | 2015-05-12 | BUY | 2,000 | $112.16 | $224.3K |
| Ausiello Dennis A | Director | 2015-04-21 | SELL | 8,165 | $130.02 | $1061.6K |
| SCHIMMEL PAUL | Director | 2015-04-21 | SELL | 10,000 | $130.02 | $1300.2K |
| SCHIMMEL PAUL | Director | 2015-03-19 | SELL | 10,000 | $120 | $1200K |
| Ausiello Dennis A | Director | 2015-03-19 | SELL | 5,000 | $120 | $600K |
| Vaishnaw Akshay | EVP, R&D, CMO | 2015-03-17 | SELL | 8,750 | $116.86 | $1022.5K |
| Ausiello Dennis A | Director | 2015-03-05 | SELL | 706 | $115 | $81.2K |
| Fanucci Marsha | Director | 2015-02-25 | SELL | 10,000 | $105.8 | $1058K |
| Sanofi | 10% Owner | 2015-01-29 | BUY | 97,118 | $95 | $9226.2K |
| Sanofi | 10% Owner | 2015-01-26 | BUY | 647,448 | $95 | $61507.6K |
| MARAGANORE JOHN | CEO | 2015-01-26 | BUY | 10,000 | $95 | $950K |
| PAUL STEVEN M | Director | 2015-01-26 | BUY | 1,000 | $95 | $95K |
| Sanofi | 10% Owner | 2015-01-22 | BUY | 196,251 | $93.17 | $18284.7K |
| Greene Barry E | President and COO | 2014-12-19 | SELL | 11,200 | $100 | $1120K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2014-12-16 | SELL | 10,626 | $93.6 | $994.6K |
| Mason Michael | VP, Finance and Treasurer | 2014-12-15 | SELL | 22,162 | $97.5 | $2160.8K |
| SCHIMMEL PAUL | Director | 2014-12-08 | SELL | 15,000 | $105 | $1575K |
| Ausiello Dennis A | Director | 2014-12-08 | SELL | 15,000 | $108.33 | $1625K |
| Reid Laurence | SVP, Chief Business Officer | 2014-11-18 | SELL | 10,000 | $90.67 | $906.7K |
| Greene Barry E | President and COO | 2014-11-17 | SELL | 33,200 | $89.63 | $2975.7K |
| Ausiello Dennis A | Director | 2014-11-11 | SELL | 5,000 | $100 | $500K |
| Greene Barry E | President and COO | 2014-11-11 | SELL | 11,100 | $100 | $1110K |
| SCHIMMEL PAUL | Director | 2014-10-28 | SELL | 15,000 | $95 | $1425K |
| Ausiello Dennis A | Director | 2014-10-22 | SELL | 5,000 | $90 | $450K |
| SHARP PHILIP A | Director | 2014-10-13 | SELL | 110,000 | $85 | $9350K |
| STARR KEVIN P | Director | 2014-09-25 | SELL | 90,000 | $78.09 | $7028.1K |
| MARAGANORE JOHN | CEO | 2014-09-18 | SELL | 113,668 | $77.71 | $8833.1K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2014-09-16 | SELL | 10,625 | $72.04 | $765.4K |
| Reid Laurence | SVP, Chief Business Officer | 2014-08-18 | SELL | 13,500 | $67.34 | $909.1K |
| MARAGANORE JOHN | CEO | 2014-06-26 | SELL | 113,668 | $65.45 | $7439.6K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2014-06-17 | SELL | 10,625 | $69.82 | $741.8K |
| CLARKE JOHN K | Director | 2014-05-21 | SELL | 35,000 | $53.8 | $1883K |
| Reid Laurence | SVP, Chief Business Officer | 2014-05-19 | SELL | 13,500 | $57.83 | $780.7K |
| MARAGANORE JOHN | CEO | 2014-05-15 | SELL | 113,668 | $56.73 | $6448.4K |
| Sanofi | 10% Owner | 2014-03-25 | BUY | 344,448 | $66.88 | $23036.7K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2014-03-18 | SELL | 32,769 | $73.95 | $2423.3K |
| Reid Laurence | SVP, Chief Business Officer | 2014-02-19 | SELL | 20,400 | $80.06 | $1633.2K |
| Mason Michael | VP, Finance and Treasurer | 2014-02-03 | SELL | 3,750 | $78.66 | $295K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2014-01-24 | SELL | 7,890 | $85.75 | $676.6K |
| SCHIMMEL PAUL | Director | 2014-01-13 | SELL | 15,000 | $85.36 | $1280.4K |
| SCHIMMEL PAUL | Director | 2013-12-20 | SELL | 15,000 | $65 | $975K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2013-12-17 | SELL | 33,480 | $60.72 | $2032.9K |
| Mason Michael | VP, Finance and Treasurer | 2013-12-16 | SELL | 8,000 | $60.36 | $482.9K |
| Mason Michael | VP, Finance and Treasurer | 2013-12-02 | SELL | 3,750 | $61.83 | $231.9K |
| Reid Laurence | SVP, Chief Business Officer | 2013-11-13 | SELL | 13,500 | $53.36 | $720.4K |
| SCHIMMEL PAUL | Director | 2013-10-22 | SELL | 15,000 | $60 | $900K |
| MARAGANORE JOHN | CEO | 2013-09-11 | SELL | 58,947 | $55.5 | $3271.6K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2013-09-10 | SELL | 6,250 | $57.48 | $359.3K |
| MARAGANORE JOHN | CEO | 2013-08-14 | SELL | 60,000 | $48.97 | $2938.2K |
| Mason Michael | VP, Finance & Treasurer | 2013-07-12 | SELL | 14,200 | $50 | $710K |
| MARAGANORE JOHN | CEO | 2013-07-10 | SELL | 60,000 | $37.11 | $2226.6K |
| Mason Michael | VP, Finance and Treasurer | 2013-07-01 | SELL | 27,000 | $32 | $864K |
| Mason Michael | VP, Finance and Treasurer | 2013-06-17 | SELL | 23,625 | $29.93 | $707.1K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2013-06-11 | SELL | 15,000 | $31.08 | $466.2K |
| Greene Barry E | President and COO | 2013-05-28 | SELL | 22,822 | $30 | $684.7K |
| Reid Laurence | SVP and Chief Business Officer | 2013-05-28 | SELL | 5,000 | $30 | $150K |
| STARR KEVIN P | Director | 2013-03-26 | SELL | 52,631 | $23.49 | $1236.3K |
| Greene Barry E | President & COO | 2013-03-14 | SELL | 24,058 | $25 | $601.5K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2013-03-11 | SELL | 6,250 | $24.55 | $153.4K |
| Greene Barry E | President and COO | 2013-03-08 | SELL | 24,000 | $24.43 | $586.3K |
| MARAGANORE JOHN | CEO | 2013-02-28 | SELL | 58,503 | $23.48 | $1373.7K |
| Reid Laurence | SVP, Chief Business Officer | 2013-02-08 | SELL | 5,000 | $25 | $125K |
| SHARP PHILIP A | Director | 2013-01-22 | BUY | 4,967 | $20.13 | $100K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2012-12-12 | SELL | 14,777 | $18.35 | $271.2K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2012-12-04 | SELL | 2,400 | $17.04 | $40.9K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2012-11-30 | SELL | 2,823 | $17.03 | $48.1K |
| Mason Michael | VP, Finance and Treasurer | 2012-11-30 | SELL | 3,750 | $16.93 | $63.5K |
| NOVARTIS AG | 10% Owner | 2012-09-20 | SELL | 1,551,896 | $19.42 | $30137.8K |
| Vaishnaw Akshay | EVP, Chief Medical Officer | 2012-09-12 | SELL | 6,250 | $19 | $118.8K |
| Vaishnaw Akshay | SVP, Chief Medical Officer | 2012-07-16 | SELL | 36,250 | $19 | $688.8K |
| Mason Michael | VP, Finance & Treasurer | 2012-07-16 | SELL | 15,295 | $18.57 | $284K |
| Fanucci Marsha | Director | 2012-02-21 | BUY | 10,000 | $10.75 | $107.5K |
| Reid Laurence | SVP, Chief Business Officer | 2012-02-21 | BUY | 930 | $10.75 | $10K |
| Greene Barry E | President and COO | 2012-02-21 | BUY | 1,860 | $10.75 | $20K |
| MARAGANORE JOHN | CEO | 2012-02-21 | BUY | 5,581 | $10.75 | $60K |
| SHARP PHILIP A | Director | 2012-02-21 | BUY | 9,302 | $10.75 | $100K |
| SCHIMMEL PAUL | Director | 2012-02-21 | BUY | 93,023 | $10.75 | $1000K |
| Greene Barry E | President and COO | 2012-01-09 | BUY | 567 | $8.8 | $5K |
| MARAGANORE JOHN | CEO | 2012-01-09 | BUY | 1,134 | $8.81 | $10K |
| Greene Barry E | President and COO | 2011-12-12 | BUY | 699 | $7.15 | $5K |
| MARAGANORE JOHN | CEO | 2011-12-12 | BUY | 1,397 | $7.15 | $10K |
| MARAGANORE JOHN | CEO | 2011-11-14 | BUY | 1,411 | $7.08 | $10K |
| Greene Barry E | President and COO | 2011-11-14 | BUY | 704 | $7.09 | $5K |
| Greene Barry E | President and COO | 2011-10-11 | BUY | 742 | $6.73 | $5K |
| MARAGANORE JOHN | CEO | 2011-10-11 | BUY | 1,480 | $6.75 | $10K |
| VINCENT JAMES L | Director | 2010-06-18 | SELL | 22,100 | $15.21 | $336.1K |
| VINCENT JAMES L | Director | 2010-06-15 | SELL | 30,000 | $16 | $480K |
| VINCENT JAMES L | Director | 2010-06-14 | SELL | 32,900 | $16.03 | $527.4K |
| NOVARTIS AG | 10% Owner | 2010-04-23 | BUY | 55,223 | $17.99 | $993.5K |
| SCHIMMEL PAUL | Director | 2009-09-10 | SELL | 45,600 | $22.15 | $1010K |
| SCHIMMEL PAUL | Director | 2009-09-04 | SELL | 29,400 | $22.02 | $647.4K |
| MARAGANORE JOHN | CEO | 2009-06-18 | SELL | 120,000 | $21.4 | $2568K |
| NOVARTIS AG | 10% Owner | 2009-05-06 | BUY | 65,922 | $17.5 | $1153.6K |
| Allen Patricia L | VP of Finance/Treasurer | 2009-04-22 | SELL | 25,000 | $17.63 | $440.8K |
| POLARIS VENTURE MANAGEMENT CO | 10% Owner | 2004-12-14 | SELL | 166,500 | $6.52 | $1085.6K |
| POLARIS VENTURE MANAGEMENT CO | 10% Owner | 2004-12-10 | SELL | 37,000 | $6.76 | $250.1K |
Congress & Senate Trades
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Unknown
Guru Activity
1 gurus tracked